Vacis Tatarunas
Overview
Explore the profile of Vacis Tatarunas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
cereskevicius D, ciapiene I, Aldujeli A, Zabiela V, Lesauskaite V, Zubieliene K, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076958
Hypercholesterolemia, characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C), along with inflammation, is a well-known risk factor for developing atherosclerosis and coronary artery disease (CAD). Many patients with hypercholesterolemia...
2.
Aldujeli A, Tsai T, Haq A, Tatarunas V, Garg S, Hughes D, et al.
Atherosclerosis
. 2024 Sep;
398:118597.
PMID: 39316928
Background And Aims: Coronary microvascular dysfunction (CMD) is common after ST-elevation myocardial infarction (STEMI), leading to adverse clinical outcomes. However, its diagnosis remains difficult, and mechanisms elusive. This study explores...
3.
cereskevicius D, Zabiela V, Aldujeli A, Lesauskaite V, Zubieliene K, Raskevicius V, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791422
The effectiveness of lipid-lowering therapies may be insufficient in high-risk cardiovascular patients and depends on the genetic variability of drug-metabolizing enzymes. Customizing statin therapy, including treatment with atorvastatin, may improve...
4.
Aldujeli A, Tsai T, Haq A, Tatarunas V, Knokneris A, Briedis K, et al.
J Am Heart Assoc
. 2024 Apr;
13(9):e033596.
PMID: 38686863
Background: Coronary microvascular dysfunction (CMD) is a common complication of ST-segment-elevation myocardial infarction (STEMI) and can lead to adverse cardiovascular events. Whether CMD after STEMI is associated with functional left...
5.
Stakisaitis D, Kapocius L, Tatarunas V, Gecys D, Mickiene A, Tamosuitis T, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543303
The study presents data on the anti-inflammatory effects of a combination of sodium dichloroacetate and sodium valproate (DCA-VPA) on the expression of inflammation- and immune response-related genes in T lymphocytes...
6.
Giedraitiene A, Tatarunas V, Kaminskaite K, Meskauskaite U, Boieva S, Ajima Y, et al.
Diagnostics (Basel)
. 2024 Mar;
14(5).
PMID: 38473018
Background: Ischemic heart disease (IHD) is the most prevalent type of cardiovascular disease. The main cause of IHD is atherosclerosis, which is a multifactorial inflammatory disease of blood vessels. Studies...
7.
Tatarunas V, ciapiene I, Giedraitiene A
Pharmaceutics
. 2024 Feb;
16(2).
PMID: 38399346
Interindividual variability in drug response is a major problem in the prescription of pharmacological treatments. The therapeutic effect of drugs can be influenced by human genes. Pharmacogenomic guidelines for individualization...
8.
Tamakauskas V, Zaliunas R, Lesauskaite V, Kupstyte-Kristapone N, ciapiene I, Sakalyte G, et al.
Drug Des Devel Ther
. 2024 Jan;
18:109-119.
PMID: 38287944
Purpose: The aim of this study was to determine the effect of genetic polymorphism and renal function on the occurrence of ticagrelor-related dyspnea. Patients And Methods: A total of 299...
9.
Aldujeli A, Haq A, Tsai T, Grabauskyte I, Tatarunas V, Briedis K, et al.
Sci Rep
. 2023 Nov;
13(1):20094.
PMID: 37973856
Coronary microvascular dysfunction (CMD) is a common complication of ST-segment elevation myocardial infarction (STEMI) and can lead to adverse cardiovascular events. This is a non-randomized, observational, prospective study of STEMI...
10.
Matuleviciute I, Tatarunas V, Skipskis V, ciapiene I, Veikutiene A, Lesauskaite V, et al.
Eye (Lond)
. 2023 Aug;
38(2):372-379.
PMID: 37587376
Background/objectives: To investigate the associations between ophthalmic parameters, CYP4F2 (rs2108622) and ABCA1 (rs1883025) polymorphisms and coronary artery disease, considering the accessibility, non-invasive origin of retinal examination and its possible resemblance...